Sonnet BioTherapeutics (SONN) Institutional Ownership $1.31 0.00 (0.00%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 03/28/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sonnet BioTherapeutics (NASDAQ:SONN)CurrentInstitutional OwnershipPercentage9.45%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$340.92KNumber ofInstitutional Sellers(last 12 months)0 Get SONN Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SONN Institutional Buying and Selling by Quarter Remove Ads Sonnet BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP19,203$28K0.0%N/A0.630% 2/11/2025 Virtu Financial LLC39,647$58K0.0%N/A1.300% 8/15/2024 Armistice Capital LLC272,000$255K0.0%N/A8.740% 7/27/2023 Virtu Financial LLC86,624$42K0.0%N/A0.315% 5/19/2023 Anson Funds Management LP1,760,000$634K0.1%N/A6.405% 11/7/2022 Virtu Financial LLC26,914$40K0.0%N/A0.622% 8/2/2022 Advisory Services Network LLC130,525$37K0.0%+158.3%0.215% 5/10/2022 Campion Asset Management90,612$34K0.0%N/A0.150% 8/16/2021 State Street Corp62,688$99K0.0%N/A0.253% 8/13/2021 Vanguard Group Inc.701,634$1.11M0.0%+416.0%2.834% 5/19/2021 Virtu Financial LLC65,106$146K0.0%N/A0.371% 5/18/2021 Citadel Advisors LLC113,264$255K0.0%N/A0.534% 5/18/2021 Jane Street Group LLC17,304$39K0.0%N/A0.099% 5/17/2021 Price T Rowe Associates Inc. MD45,100$101K0.0%N/A0.257% 5/13/2021 Bank of New York Mellon Corp20,399$46K0.0%N/A0.116% 5/7/2021BlackRock Inc.255,761$575K0.0%+3.7%1.457% 3/26/2021 Susquehanna International Group LLP15,434$34K0.0%N/A0.088% 2/5/2021BlackRock Inc.246,555$550K0.0%+2.5%1.435% (Data available from 1/1/2016 forward)Remove Ads SONN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SONN shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonnet BioTherapeutics shares: Anson Funds Management LP ($634K), Armistice Capital LLC ($255K), and Virtu Financial LLC ($58K), Two Sigma Investments LP ($28K).Learn more on SONN's institutional investors. What percentage of Sonnet BioTherapeutics stock is owned by institutional investors? 9.45% of Sonnet BioTherapeutics stock is owned by institutional investors. Learn more on SONN's institutional investor holdings. Which institutional investors have been buying Sonnet BioTherapeutics stock? The following institutional investors have purchased Sonnet BioTherapeutics stock in the last 24 months: Anson Funds Management LP ($1.76M), Armistice Capital LLC ($272K), Virtu Financial LLC ($126.27K), and Two Sigma Investments LP ($19.20K). How much institutional buying is happening at Sonnet BioTherapeutics? Institutional investors have bought a total of 2,177,474 shares in the last 24 months. This purchase volume represents approximately $15.21M in transactions. Related Companies NextCure Institutional Ownership GlycoMimetics Institutional Ownership BriaCell Therapeutics Institutional Ownership Carisma Therapeutics Institutional Ownership Sol-Gel Technologies Institutional Ownership MEI Pharma Institutional Ownership Imunon Institutional Ownership Synlogic Institutional Ownership Leap Therapeutics Institutional Ownership NeuroSense Therapeutics Institutional Ownership This page (NASDAQ:SONN) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SONN Stock Free SONN Stock Alerts